Early oral cysteamine therapy for nephropathic cystinosis
- 11 November 2003
- journal article
- review article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 162 (1) , S38-S41
- https://doi.org/10.1007/s00431-003-1349-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cystinosin, the protein defective in cystinosis, is a H+-driven lysosomal cystine transporterThe EMBO Journal, 2001
- Corneal Crystals in Nephropathic Cystinosis: Natural History and Treatment with Cysteamine EyedropsMolecular Genetics and Metabolism, 2000
- Identification and Detection of the Common 65-kb Deletion Breakpoint in the Nephropathic Cystinosis Gene (CTNS)Molecular Genetics and Metabolism, 1999
- CTNS Mutations in an American-Based Population of Cystinosis PatientsAmerican Journal of Human Genetics, 1998
- A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosisNature Genetics, 1998
- Classic Nephropathic Cystinosis as an Adult DiseaseJAMA, 1993
- Parenchymal organ cystine depletion with long-term cysteamine therapyBiochemical Medicine and Metabolic Biology, 1992
- A Randomized Placebo-Controlled Trial of Cysteamine Eye Drops in Nephropathic CystinosisArchives of Ophthalmology (1950), 1990
- Complications of nephropathic cystinosis after renal failurePediatric Nephrology, 1987
- Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?Journal of Biological Chemistry, 1985